Cost-saving analysis

Milliman Specialty Pharmacy Insights

Identify opportunities to manage specialty pharmacy costs for existing and new drug therapies.

Milliman Specialty Pharmacy Insights

The challenge

Managing specialty drug costs is time consuming and demands up-to-date information

Specialty pharmacy costs have consistently increased at a higher rate than overall healthcare and pharmacy costs, and this trend is expected to continue. High-cost drugs entering the market typically have large variability in uptake and create significant uncertainty, yet it is challenging to know when therapeutic alternatives and other cost-saving measures are viable.

The solution

Identify opportunities for savings and better care using an intuitive tool

Get the power of in-depth data and advanced models through an easy-to-use, web-based solution. Specialty Pharmacy Insights provides the insight you need to manage specialty drug utilization and costs while delivering equivalent treatment options for patients.

BENEFITS

Specialty Pharmacy Insights benefits

Save money

Review the viability of shifting site of care, dose optimization, and biosimilar drugs.

Maintain a focus on patient care

Understand which treatments provide high value outcomes based on individual patient characteristics.

Stay informed about new treatments

Learn when new specialty drugs are expected to launch in the market and how your specialty pharmacy spend and utilization compares to others.

Access anytime

Open the Specialty Pharmacy Insights dashboard and download reports and files through a secure, web-based interface.

FEATURES

Specialty Pharmacy Insights features

Accurate results

The latest models and clinically-validated identification techniques to accurately identify medical and pharmacy spend optimization opportunities.

Cloud computing

Our newest technologies use the latest cloud technologies and RESTful APIs to maximize scalability and provide clients maximum integration flexibility.

Rare condition identification

Identify patients whose diagnosis codes indicate they may have a treatable disease using currently approved or FDA pipeline drugs.

SERVICES

Milliman Specialty Pharmacy Insights